Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

NCT06366451

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • UC Davis Sacramento, California, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Oregon Health & Science University (OHSU) Portland, Oregon, United States
View Trial Details
Completed

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

NCT04997902

Conditions
Carcinoma, Carcinoma, Squamous Cell, Congenital Abnormalities, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Lake Nona DDU (Florida Cancer Specialists) Orlando, Florida, United States
  • University of Maryland School of Medicine (Marlene and Stewart Greenebaum Comprehensive Cancer Center) Baltimore, Maryland, United States
  • Johns Hopkins University School of Medicine (Sidney Kimmel Comprehensive Cancer Center) Baltimore, Maryland, United States
View Trial Details
Completed

Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.

NCT04881045

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +33 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 43 locations
View Trial Details
Completed

A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

NCT06010303

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 38 locations
View Trial Details
Completed

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

NCT02254278

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 222 locations
View Trial Details

Related conditions